SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001493152-24-004360
Filing Date
2024-01-30
Accepted
2024-01-30 17:25:47
Documents
53

Document Format Files

Seq Description Document Type Size
1 forms-4a.htm   iXBRL S-4/A 6727952
2 ex23-1.htm EX-23.1 4241
3 ex23-2.htm EX-23.2 4059
4 annexg_001.jpg GRAPHIC 371478
5 annexg_002.jpg GRAPHIC 398762
6 annexg_003.jpg GRAPHIC 306021
7 forms-4a_001.jpg GRAPHIC 9814
8 forms-4a_002.jpg GRAPHIC 10305
9 forms-4a_003.jpg GRAPHIC 11875
10 forms-4a_004.jpg GRAPHIC 6254
  Complete submission text file 0001493152-24-004360.txt   14207124

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE tenk-20230930.xsd EX-101.SCH 29194
12 XBRL CALCULATION FILE tenk-20230930_cal.xml EX-101.CAL 30275
13 XBRL DEFINITION FILE tenk-20230930_def.xml EX-101.DEF 176011
14 XBRL LABEL FILE tenk-20230930_lab.xml EX-101.LAB 231450
15 XBRL PRESENTATION FILE tenk-20230930_pre.xml EX-101.PRE 204084
54 EXTRACTED XBRL INSTANCE DOCUMENT forms-4a_htm.xml XML 841027
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
TenX Keane Acquisition (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-275506 | Film No.: 24579699
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)